|
|
Volumn 17, Issue 5, 2000, Pages 1037-1041
|
|
New aromatase inhibitors in the treatment of advanced breast cancer.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANASTROZOLE;
ANDROSTANE DERIVATIVE;
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
AROMATASE INHIBITOR;
ENZYME INHIBITOR;
ESTROGEN;
EXEMESTANE;
LETROZOLE;
NITRILE;
TRIAZOLE DERIVATIVE;
TUMOR PROTEIN;
BREAST TUMOR;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DOUBLE BLIND PROCEDURE;
DRUG ANTAGONISM;
ENZYMOLOGY;
FEMALE;
HUMAN;
MULTICENTER STUDY;
NEOPLASM;
PATHOLOGY;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
POSTMENOPAUSE;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
ANDROSTADIENES;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, HORMONAL;
AROMATASE INHIBITORS;
BREAST NEOPLASMS;
CLINICAL TRIALS, PHASE I;
CLINICAL TRIALS, PHASE II;
CLINICAL TRIALS, PHASE III;
DOUBLE-BLIND METHOD;
ENZYME INHIBITORS;
ESTROGENS;
FEMALE;
HUMANS;
MULTICENTER STUDIES;
NEOPLASM PROTEINS;
NEOPLASMS, HORMONE-DEPENDENT;
NITRILES;
POSTMENOPAUSE;
RANDOMIZED CONTROLLED TRIALS;
TRIAZOLES;
MLCS;
MLOWN;
|
|
EID: 0034321764
PISSN: 10196439
EISSN: None
Source Type: Journal
DOI: 10.3892/ijo.17.5.1037 Document Type: Review |
|
Times cited : (9)
|
|
References (34)
|
